article thumbnail

A Forthcoming Shift of Pharmaceutical Sales Compensation Plans?

OpenSymmetry

Sales in the pharmaceutical industry has been a rigid and consistent business. In some cases, incentive compensation (IC) methods have evolved to align with new regulations regarding specific sales metrics. Firstly, organizations will need to become more reliant on Anonymous Patient-Level Data (APLD).

article thumbnail

A Forthcoming Shift of Pharmaceutical Sales Compensation Plans?

OpenSymmetry

Sales in the pharmaceutical industry has been a rigid and consistent business. In some cases, incentive compensation (IC) methods have evolved to align with new regulations regarding specific sales metrics. Firstly, organizations will need to become more reliant on Anonymous Patient-Level Data (APLD).